Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...
Hosted on MSN22d
Cardiogenic shock team cuts time to diagnosis by halfThe article "Improving Cardiogenic Shock Team Activation ... and other clinicians know when to escalate a patient's treatment to the shock pathway." Educating the nursing team was one of the ...
Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...
Phase 1 results support further evaluation of ALLO-316 in patients with CD70-positive clear cell renal cell carcinoma, according to researchers.
Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...
Treatment with landiolol resulted in decreased ... decompensated heart failure, cardiogenic shock, pulmonary hypertension, or hypersensitivity reactions. Rapiblyk is supplied as a lyophilized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback